GH Research Plc (GHRS)
27.94
-0.70
(-2.46%)
USD |
NASDAQ |
Aug 28, 16:00
27.94
0.00 (0.00%)
After-Hours: 18:34
GH Research Cash from Operations (Quarterly) : -14.94M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.94M |
| March 31, 2026 | -10.67M |
| December 31, 2025 | -12.26M |
| September 30, 2025 | -14.46M |
| June 30, 2025 | -9.630M |
| March 31, 2025 | -8.573M |
| December 31, 2024 | -9.516M |
| September 30, 2024 | -12.72M |
| June 30, 2024 | -9.858M |
| March 31, 2024 | -9.596M |
| December 31, 2023 | -7.740M |
| Date | Value |
|---|---|
| September 30, 2023 | -10.40M |
| June 30, 2023 | -8.133M |
| March 31, 2023 | -6.885M |
| December 31, 2022 | -7.213M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -6.001M |
| December 31, 2021 | -3.440M |
| September 30, 2021 | -9.571M |
| June 30, 2021 | -0.6818M |
| March 31, 2021 | -1.087M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Atai Beckley, Inc. | -35.09M |
| Avadel Pharmaceuticals Plc | 23.27M |
| Jazz Pharmaceuticals Plc | 415.70M |
| Eli Lilly & Co. | 10.69B |
| Perrigo Co. Plc | 82.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.295M |
| Cash from Financing (Quarterly) | 111.51M |
| Free Cash Flow | -52.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2248 |
| Free Cash Flow to Equity (Quarterly) | -14.88M |
| Free Cash Flow to Firm (Quarterly) | -14.87M |
| Free Cash Flow Yield | -2.97% |